X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2973) 2973
male (2284) 2284
female (2247) 2247
middle aged (1971) 1971
nasopharyngeal carcinoma (1942) 1942
adult (1805) 1805
aged (1500) 1500
nasopharyngeal neoplasms - mortality (1457) 1457
oncology (1433) 1433
cancer (1363) 1363
nasopharyngeal neoplasms - pathology (1130) 1130
prognosis (1088) 1088
carcinoma (993) 993
radiotherapy (886) 886
nasopharyngeal neoplasms - radiotherapy (805) 805
adolescent (788) 788
neoplasm staging (742) 742
retrospective studies (717) 717
chemotherapy (667) 667
survival rate (593) 593
treatment outcome (544) 544
survival (535) 535
metastasis (517) 517
young adult (496) 496
disease-free survival (490) 490
follow-up studies (465) 465
nasopharyngeal neoplasms - therapy (464) 464
otorhinolaryngology (443) 443
care and treatment (438) 438
aged, 80 and over (422) 422
nasopharyngeal cancer (420) 420
surgery (397) 397
child (387) 387
survival analysis (380) 380
nasopharyngeal neoplasms - drug therapy (378) 378
carcinoma - mortality (376) 376
head (375) 375
analysis (373) 373
research (361) 361
risk factors (354) 354
radiation therapy (352) 352
tumors (337) 337
radiology, nuclear medicine & medical imaging (328) 328
radiation-therapy (321) 321
kaplan-meier estimate (317) 317
carcinoma, squamous cell - mortality (305) 305
radiotherapy dosage (304) 304
intensity-modulated radiotherapy (297) 297
combined modality therapy (296) 296
carcinoma - pathology (294) 294
medical prognosis (282) 282
patients (282) 282
squamous-cell carcinoma (276) 276
chemoradiotherapy (267) 267
health aspects (264) 264
cancer therapies (261) 261
antineoplastic combined chemotherapy protocols - therapeutic use (259) 259
nasopharyngeal neoplasms - epidemiology (256) 256
multivariate analysis (253) 253
nasopharyngeal neoplasms - diagnosis (251) 251
expression (243) 243
proportional hazards models (234) 234
nasopharyngeal neoplasms - metabolism (233) 233
time factors (232) 232
immunohistochemistry (231) 231
nasopharyngeal neoplasms - genetics (225) 225
hematology, oncology and palliative medicine (219) 219
epstein-barr-virus (217) 217
cell line, tumor (214) 214
carcinoma - radiotherapy (211) 211
lymphatic metastasis (210) 210
mortality (205) 205
diagnosis (204) 204
radiation (200) 200
cisplatin (195) 195
epidemiology (193) 193
neoplasm metastasis (193) 193
research article (192) 192
carcinoma, squamous cell - pathology (189) 189
animals (188) 188
medicine (187) 187
neck (187) 187
metastases (185) 185
neoplasms. tumors. oncology. including cancer and carcinogens (184) 184
neoplasm recurrence, local - mortality (181) 181
studies (178) 178
neck-cancer (176) 176
head and neck cancer (175) 175
incidence (175) 175
nasopharyngeal neoplasms - surgery (175) 175
proteins (175) 175
development and progression (174) 174
gene expression regulation, neoplastic (174) 174
carcinoma, squamous cell - radiotherapy (173) 173
cisplatin - administration & dosage (172) 172
apoptosis (170) 170
patient outcomes (168) 168
risk (164) 164
gene expression (163) 163
head and neck neoplasms - mortality (161) 161
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3040) 3040
Chinese (66) 66
French (25) 25
German (23) 23
Japanese (23) 23
Italian (12) 12
Russian (7) 7
Spanish (5) 5
Polish (3) 3
Croatian (2) 2
Hebrew (2) 2
Arabic (1) 1
Danish (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 2017, Volume 123, Issue 9, pp. 1566 - 1575
BACKGROUND Human papillomavirus (HPV) is a well‐established prognostic marker for oropharyngeal squamous cell cancer (OPSCC). Because of the limited numbers of... 
human papillomavirus (HPV) | head and neck squamous cell cancer (HNSCC) | p16 | race | sex | oropharyngeal squamous cell cancer (OPSCC) | prognosis | UNITED-STATES | POSITIVE HEAD | IN-SITU HYBRIDIZATION | IMPROVED SURVIVAL | TRIAL | NASOPHARYNGEAL CARCINOMA | HPV STATUS | THERAPY | ONCOLOGY | IMMUNOHISTOCHEMISTRY | Oropharyngeal Neoplasms - ethnology | Head and Neck Neoplasms - virology | Nasopharyngeal Neoplasms - mortality | Prognosis | Asian Americans - statistics & numerical data | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Nasopharyngeal Neoplasms - ethnology | Nasopharyngeal Neoplasms - virology | Oropharyngeal Neoplasms - mortality | Hispanic Americans - statistics & numerical data | Male | Oropharyngeal Neoplasms - pathology | Carcinoma, Squamous Cell - ethnology | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Mouth Neoplasms - ethnology | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Head and Neck Neoplasms - ethnology | Laryngeal Neoplasms - ethnology | Female | Papillomavirus Infections - virology | Retrospective Studies | Repressor Proteins - metabolism | Oncogene Proteins, Viral - metabolism | Ethnic Groups - statistics & numerical data | Papillomavirus Infections - epidemiology | Proportional Hazards Models | European Continental Ancestry Group - statistics & numerical data | Oropharyngeal Neoplasms - virology | Mouth Neoplasms - virology | Mouth Neoplasms - mortality | Human papillomavirus 16 - metabolism | Head and Neck Neoplasms - pathology | African Americans - statistics & numerical data | Papillomavirus E7 Proteins - metabolism | Laryngeal Neoplasms - mortality | Sex Factors | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Mouth Neoplasms - pathology | Head and Neck Neoplasms - mortality | Neoplasm Staging | DNA, Viral | Human papillomavirus 16 - genetics | Laryngeal Neoplasms - virology | Complications and side effects | Care and treatment | DNA | Head and neck cancer | Research | Papillomavirus infections | Risk factors | Sex | Risk | Population studies | mRNA | Nasopharynx | Human papillomavirus | Race | Larynx | Deoxyribonucleic acid--DNA | Squamous cell carcinoma | Head | Adjustment | Mortality | Health risks | Hazards | Ribonucleic acid--RNA | Minority & ethnic groups | Patients | Survival | Oral cavity | Tobacco | Medical prognosis | Men | Health hazards | Health risk assessment | Hispanics | Cancer | Tumors
Journal Article
by Ma, YC and Chen, HB and Ma, HY and Yao, ZH and Hu, JW and Ma, J and Zhang, XQ and Chen, GW and Liu, YC
SAUDI MEDICAL JOURNAL, ISSN 0379-5284, 08/2019, Volume 40, Issue 8, pp. 755 - 765
Objectives: To analyze the heterogeneous functions of secreted protein acidic and rich in cysteine (SPARC) from different origins and in different tumor... 
SURVIVAL | LUNG-CANCER | PREDICTS | MEDICINE, GENERAL & INTERNAL | GASTRIC-CANCER | PANCREATIC-CANCER | MARKERS | SPARC EXPRESSION | GEMCITABINE | PROGRESSION | PACLITAXEL | Esophageal Squamous Cell Carcinoma - metabolism | Neoplasms - metabolism | Nasopharyngeal Neoplasms - metabolism | Nasopharyngeal Neoplasms - mortality | Pancreatic Neoplasms - metabolism | Prognosis | Lung Neoplasms - mortality | Humans | Lung Neoplasms - metabolism | Stomach Neoplasms - metabolism | Tumor Microenvironment | Biliary Tract Neoplasms - mortality | Lymphoma, Large B-Cell, Diffuse - metabolism | Breast Neoplasms - metabolism | Esophageal Neoplasms - metabolism | Biliary Tract Neoplasms - metabolism | Esophageal Neoplasms - mortality | Pancreatic Neoplasms - mortality | Colorectal Neoplasms - metabolism | Colorectal Neoplasms - mortality | Nasopharyngeal Carcinoma - mortality | Proportional Hazards Models | Neoplasms - mortality | Osteonectin - metabolism | Nasopharyngeal Carcinoma - metabolism | Survival Rate | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Esophageal Squamous Cell Carcinoma - mortality | Breast Neoplasms - mortality | Stomach Neoplasms - mortality | Medical research | Cysteine | Care and treatment | Analysis | Pancreatic cancer | Colorectal cancer | Medicine, Experimental | Development and progression | Cystine | Proteins | Angiogenesis | Medical prognosis | Bias | Fibroblasts | Lymphomas | Metastasis | Stomach cancer | Tumors | Cell adhesion & migration | Meta-analysis | Systematic Review | meta-analysis | SPARC | tumor microenvironment | prognosis | stroma
Journal Article
CA: a cancer journal for clinicians, ISSN 0007-9235, 2015, Volume 65, Issue 2, pp. 87 - 108
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 87, Issue 5, pp. 1086 - 1093
Purpose To assess the dosimetric benefit, treatment outcome, and toxicity of high-dose and extended-field intensity modulated radiation therapy (IMRT) in... 
Radiology | Hematology, Oncology and Palliative Medicine | HEAD | NASOPHARYNGEAL CARCINOMA | PROGNOSTIC-FACTORS | ONCOLOGY | NASAL-TYPE | ARC THERAPY | TOXICITY | EXPERIENCE | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | NECK CANCER | CHEMOTHERAPY | Organs at Risk - radiation effects | Pharyngeal Neoplasms - radiotherapy | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Pharyngeal Neoplasms - drug therapy | Nasopharyngeal Neoplasms - pathology | Young Adult | Child | Radiotherapy Planning, Computer-Assisted | Lymphatic Irradiation - methods | Radiotherapy, Intensity-Modulated - mortality | Radiotherapy Dosage | Nasopharyngeal Neoplasms - diagnostic imaging | Nose Neoplasms - pathology | Oropharyngeal Neoplasms - drug therapy | Radiotherapy, Intensity-Modulated - methods | Oropharyngeal Neoplasms - radiotherapy | Pharyngeal Neoplasms - diagnostic imaging | Pharyngeal Neoplasms - mortality | Radiography | Lymphoma, Extranodal NK-T-Cell - pathology | Parotid Gland - radiation effects | Adolescent | Organs at Risk - diagnostic imaging | Lymphoma, Extranodal NK-T-Cell - mortality | Pharyngeal Neoplasms - pathology | Xerostomia - etiology | Nasopharyngeal Neoplasms - mortality | Oropharyngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - mortality | Radiotherapy, Intensity-Modulated - adverse effects | Organ Sparing Treatments - methods | Nasopharyngeal Neoplasms - radiotherapy | Lymphoma, Extranodal NK-T-Cell - drug therapy | Lymphoma, Extranodal NK-T-Cell - radiotherapy | Nose Neoplasms - radiotherapy | Adult | Female | Lymphatic Irradiation - adverse effects | Retrospective Studies | Nasopharyngeal Neoplasms - drug therapy | Neck | Parotid Gland - diagnostic imaging | Neoplasm Invasiveness | Treatment Outcome | Xerostomia - prevention & control | Disease-Free Survival | Lymphoma, Extranodal NK-T-Cell - diagnostic imaging | Care and treatment | Lymphomas | Radiotherapy | Nuclear radiation | Patient outcomes | Index Medicus | LYMPHOMAS | GLANDS | LYMPH NODES | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | GY RANGE 10-100 | PLANNING
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2014, Volume 9, Issue 11, p. e112581
Background: Several inflammation-based prognostic scoring systems, including Glasgow Prognostic Score (GPS), neutrophil to lymphocyte ratio (NLR) and platelet... 
SYSTEMIC INFLAMMATION | LUNG-CANCER | CACHEXIA | THERAPY | IV COLORECTAL-CANCER | MULTIDISCIPLINARY SCIENCES | EBV | NEUTROPHIL-LYMPHOCYTE | PLATELET-LYMPHOCYTE RATIO | EPIDEMIOLOGY | Blood Platelets - pathology | Bone Neoplasms - mortality | Inflammation - pathology | Lung Neoplasms - drug therapy | Carcinoma | Nasopharyngeal Neoplasms - mortality | Prognosis | Area Under Curve | Lung Neoplasms - mortality | Cell Count | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Antineoplastic Agents - therapeutic use | Liver Neoplasms - mortality | Nasopharyngeal Neoplasms - pathology | Lung Neoplasms - secondary | Inflammation - drug therapy | Adult | Female | Retrospective Studies | Bone Neoplasms - drug therapy | Inflammation - diagnosis | Nasopharyngeal Neoplasms - drug therapy | Liver Neoplasms - secondary | Inflammation - mortality | Nasopharyngeal Neoplasms - diagnosis | Neutrophils - pathology | Nasopharyngeal Carcinoma | Bone Neoplasms - diagnosis | Liver Neoplasms - drug therapy | Proportional Hazards Models | Lymphocytes - pathology | Liver Neoplasms - diagnosis | Cisplatin - therapeutic use | Adolescent | Survival Analysis | Aged | Lung Neoplasms - diagnosis | Dehydrogenases | Demography | Laboratories | Colorectal cancer | Scoring | Oncology | Metastasis | Family medical history | Cancer therapies | Metastases | Proteins | Nasopharyngeal carcinoma | Demographics | Lymphocytes | Mathematical models | Deoxyribonucleic acid--DNA | Cell survival | Neutrophils | Inflammation | Stability analysis | Regression analysis | Survival | Patients | Cisplatin | Esophagus | Chemotherapy | Hospitals | Medical prognosis | Resampling | Tumors | Deoxyribonucleic acid | DNA
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 74, Issue 2, pp. 477 - 481
Purpose To describe the University of Miami experience in the treatment of small cell carcinoma of the head and neck. Methods and Materials A total of 12... 
Radiology | Hematology, Oncology and Palliative Medicine | Head and neck cancer | Small cell | Chemotherapy | Radiotherapy | ONCOLOGY | LARYNX | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Nasopharyngeal Neoplasms - mortality | Humans | Middle Aged | Male | Carcinoma, Small Cell - mortality | Universities | Nasopharyngeal Neoplasms - radiotherapy | Nose Neoplasms - radiotherapy | Parotid Neoplasms - radiotherapy | Aged, 80 and over | Laryngeal Neoplasms - drug therapy | Female | Retrospective Studies | Nasopharyngeal Neoplasms - drug therapy | Carcinoma, Small Cell - drug therapy | Carcinoma, Small Cell - radiotherapy | Head and Neck Neoplasms - drug therapy | Florida | Tonsillar Neoplasms - mortality | Disease-Free Survival | Head and Neck Neoplasms - radiotherapy | Laryngeal Neoplasms - mortality | Parotid Neoplasms - mortality | Tonsillar Neoplasms - radiotherapy | Nose Neoplasms - drug therapy | Tonsillar Neoplasms - drug therapy | Aged | Combined Modality Therapy - methods | Parotid Neoplasms - drug therapy | Head and Neck Neoplasms - mortality | Nose Neoplasms - mortality | Carcinoma | Universities and colleges | Cancer | SURGERY | HEAD | PATIENTS | CAVITIES | FAILURES | LYMPHATIC SYSTEM | CHEMOTHERAPY | PHARYNX | SURVIVAL TIME | GLANDS | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY
Journal Article